Health - Latest News Search Engine - Global and Local Breaking News

Health

Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medici...

Orforglipron is the first small molecule GLP-1 to successfully complete a Phase 3 trial, lowering A1C by an average of 1.3% to 1.6% across doses The i...

Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum's Disease at World Orphan Drug Congress USA 2025

CBL-514, Caliway's novel small molecule drug, was selected for data presentation at the World Orphan Drug Congress USA 2025, highlighting its promisin...

Caliway Selected to Present CBL-514 Phase 2 Study Results for Dercum's Disease at World Orphan Drug Congress USA 2025

Global Alzheimer's Disease Therapeutics and Diagnostics Market to Grow at 15.1% CAGR

"Emerging blood-based diagnostics and disease-modifying therapeutics set to revolutionize Alzheimer's disease market, addressing public health crisis ...

Global Alzheimer's Disease Therapeutics and Diagnostics Market to Grow at 15.1% CAGR

Caris Life Sciences to Showcase Research Highlighting the Value of Precision Oncology Collaboration at the American Association for Cancer Research An...

Caris Life Sciences to present 14 abstracts, inclusive of 2 oral presentations and 12 posters IRVING, Texas, April 17, 2025 /PRNewswire/ -- Caris Life...

Caris Life Sciences to Showcase Research Highlighting the Value of Precision Oncology Collaboration at the American Association for Cancer Research Annual Meeting 2025

GMO/Toxin Free USA Sues Perfect Day Alleging Misleading Claims About "Animal Free Dairy"

WASHINGTON, April 17, 2025 /PRNewswire/ -- Nonprofits GMO/Toxin Free USA and Organic Consumers Association filed a lawsuit against Perfect Day, Inc., ...

GMO/Toxin Free USA Sues Perfect Day Alleging Misleading Claims About "Animal Free Dairy"

Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Bispecific Antibodies for Autoimmune and Inflammatory Bo...

MIDDLETOWN, Del., April 17, 2025 /PRNewswire/ -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics the...

Earendil Labs Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Bispecific Antibodies for Autoimmune and Inflammatory Bowel Diseases

epiq Animal Health and Interpath Global Launch Second Joint Health Product Offering - This One for Dogs

DUBLIN, Ohio, April 17, 2025 /PRNewswire/ -- epiq Animal Health, a master distributor, and Interpath Global, announced a strategic partnership in Dece...

epiq Animal Health and Interpath Global Launch Second Joint Health Product Offering - This One for Dogs

FesariusTherapeutics Announces Manufacturing Agreement for DermiSphere hDRT, the first hydrogel Dermal Regeneration Template

Exclusive development, manufacturing and supply agreement with Regenity Biosciences provides FesariusTherapeutics with a reliable, long-term supply of...

FesariusTherapeutics Announces Manufacturing Agreement for DermiSphere hDRT, the first hydrogel Dermal Regeneration Template

New Clinical Trial Demonstrates Efficacy of SEBiotic® in Treating Drug-Induced Constipation

CHINO, Calif., April 17, 2025 /PRNewswire/ -- SEBiotic® (Bacillus coagulans LBSC), produced by Specialty Enzymes & Probiotics, is a spore-forming ...

New Clinical Trial Demonstrates Efficacy of SEBiotic® in Treating Drug-Induced Constipation

/C O R R E C T I O N -- STRAVA, INC./

The world's biggest team has a new coach SAN FRANCISCO, April 17, 2025 /PRNewswire/ -- Strava, the app for active people, today announced that it has ...

/C O R R E C T I O N -- STRAVA, INC./

Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]

IFINWIL®: now TGA registered in Australia Children diagnosed with neuroblastoma are on average just 2 years old2 The average survival rate of children...

Norgine welcomes TGA registration in Australia of IFINWIL® (eflornithine) for adults and children diagnosed with high-risk neuroblastoma (HRNB)[1]

World Hemophilia Day 2025 - April 17, 2025 - "Access for all: Women and girls bleed too"

MONTREAL, April 17, 2025 /PRNewswire/ - On April 17, 2025, the global bleeding disorders community will come together under the theme "Access for all:...

World Hemophilia Day 2025 - April 17, 2025 - "Access for all: Women and girls bleed too"

Strava to Acquire Runna, A Leading Running Training App

The world's biggest team has a new coach SAN FRANCISCO, April 17, 2025 /PRNewswire/ -- Strava, the app for active people, today announced that it has ...

Strava to Acquire Runna, A Leading Running Training App

Eugène Riconneaus présente ER Ocean Recherche, repensant la matière de mode en laboratoire

PARIS, 17 avril 2025 /PRNewswire/ -- L'artiste-créateur français Eugène Riconneaus dévoile ER Ocean Recherche, un projet pionnier à l'intersection du ...

Eugène Riconneaus présente ER Ocean Recherche, repensant la matière de mode en laboratoire

Saudi-Arabien und Frankreich verstärken Zusammenarbeit im Gesundheitswesen durch strategische Abkommen in den Bereichen Biotechnologie und digitale Ge...

PARIS, 17. April 2025 /PRNewswire/ -- Am zweiten Tag eines offiziellen Besuchs in Frankreich führte Seine Exzellenz Fahad Abdulrahman AlJalajel, Gesun...

Saudi-Arabien und Frankreich verstärken Zusammenarbeit im Gesundheitswesen durch strategische Abkommen in den Bereichen Biotechnologie und digitale Gesundheit

Des innovateurs en santé mondiale récompensés par les prix de l'innovation de la Semaine mondiale de la santé d'Abu Dhabi pour leur impact transformat...

Les lauréats des prix de l'innovation 2025 de l'ADGHW ont abordé l'édition génétique prénatale, la transplantation d'organes robotisée, l'administrati...

Des innovateurs en santé mondiale récompensés par les prix de l'innovation de la Semaine mondiale de la santé d'Abu Dhabi pour leur impact transformateur

IHS, LLC. Completes it's Purchase of the Prestigious Atlanta OA Center to Expand Specialty Healthcare Services in Georgia

ATLANTA, April 17, 2025 /PRNewswire/ -- IHS, LLC, a Georgia-based healthcare acquisition and management firm, is thrilled to announce the acquisition ...

IHS, LLC. Completes it's Purchase of the Prestigious Atlanta OA Center to Expand Specialty Healthcare Services in Georgia

Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration

In the preliminary findings of a study conducted with the National Taiwan University Hospital, over 50% of sample cases were reclassified as HER2-expr...

Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration

Fangzhou Launches Partnership for "AI + Hepatitis Prevention & Control Training Center" at the Greater Bay Area International Liver Disease Forum

GUANGZHOU, China, April 16, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven healthcare solutions, p...

Chang Gung Memorial Hospital Leads Global Medical Innovation with First-Ever Breast Sensory Nerve Reconstruction

TAOYUAN, April 16, 2025 /PRNewswire/ -- Advancements in breast reconstruction are taking a significant leap forward with the integration of autologous...

Chang Gung Memorial Hospital Leads Global Medical Innovation with First-Ever Breast Sensory Nerve Reconstruction